30.09.2022 • News

Arkema Ups Expansion Plans for Pebax Elastomers

Arkema has boosted its previously announced expansion plans for Pebax elastomer at its Serquigny site in France. The company will now increase capacity by 40% rather than the 25% it announced in January this year.

The project will be undertaken in two separate phases. The first will raise output by 15% in the first quarter of 2023, then by a further 25% starting in the third quarter of next year.

In addition to the French expansion, Arkema said it is currently assessing further investment opportunities, including in Asia, in order to support the growth of its global customers in the sports, consumer electronics, medical and industrial markets. Applications range from running shoes and ski boots to catheters and to flexible device screens.

Arkema cited particularly strong growth for its bio-based Pebax grade called Rnew that is derived from renewable castor beans and can be fully recycled.

“We are very excited to announce this acceleration of our Pebax elastomer capacity increase. Demand continues to grow, especially for our bio-based Pebax Rnew range”, said Erwoan Pezron, senior vice president of Arkema’s high-performance polymers business. “There is no compromise between high performance and sustainability. Our customers demand both.”

Author: Elaine Burridge, Freelance Author

(c) Arkema
(c) Arkema

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.